ClinicalTrials.gov
public full text
Public Domain
Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)
This is a double-blind, placebo-controlled, randomized study lasting 8 weeks. Purpose of the study is two-fold: first, to use a pharmacological agent to treat symptoms of PTSD, and second, to explore neurobiological mechanisms of action of guanfacine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts#1306804
- Effects of Tai Chi in Patients With Ankylosing Spondylitis Receiving Anti-tumor Necrosis Factor Alpha Therapy#890709
- A Repeat Dose Positron Emission Tomography Study With GSK1144814#916557
- The Effect of Guanfacine on Delirium in Critically Ill Patients#906969
- Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke#830619
Record · ID 1228513
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive